Poseida Therapeutics Announces Nomination of New CAR-T Development Candidate Under Collaboration with Roche by Carolyn Helms | Oct 17, 2024 | Portfolio News
New Clinical Evidence Links Ceribell Point-of-Care EEG to Shorter Hospital Stays and Better Functional Outcomes Compared to Conventional EEG by Carolyn Helms | Oct 16, 2024 | Portfolio News
OrsoBio Announces Publication of Preclinical Data on Novel Approach for Regulating Metabolic Dysfunction and Reducing Inflammation and Fibrosis by Carolyn Helms | Oct 15, 2024 | Portfolio News
CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares by Carolyn Helms | Oct 15, 2024 | Portfolio News
BioAge Labs Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares and Closing of the Concurrent Private Placement by Carolyn Helms | Oct 1, 2024 | Portfolio News
